LIDOCAINE
Thermal Radiofrequency Neurolysis
Tanta UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Thermal Radiofrequency Neurolysis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER Tanta University | N/A | D |
Same molecule, other indications
LIDOCAINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →